Alopecia by COVID-19: About a Case

Abstract

Some research that has been carried out in patients who have already undergone COVID-19, indicate that between 20%-30% of these will suffer intense hair loss, multiplied by 4 or 5 after 2 to 4 months later of the illness. This exaggerated hair loss is known as telogenic effluvium. In telogenic effluvium, it is produced by an alteration in the hair growth cycle that generates an alarming loss for a limited period of time. As in any infection or period of stress, the root of the hair weakens and months after having overcome it, the hair falls in an abnormal and exaggerated way. The objective of presenting this case is to describe one of the most important and rare dermatological manifestations, which has been derived from SARS-CoV-2 infection. We present the case of a 41-year-old female patient, who was admitted to the emergency department after presenting a clinical picture of 8 days of evolution consisting of dry cough, tachycardia and diaphoresis, for which the antigen test for SARS-CoV-2, revealing a positive result, so it was decided to enter for medical management.